Navigation Links
Kantar Health to Highlight Strategies for Accessing U.S. and EU Markets for Japan Pharma
Date:10/27/2013

New York NY (PRWEB) October 28, 2013

Kantar Health, a leading global healthcare consulting firm, and Synix will host a seminar, “The Keys to Market Access Success in the U.S. and European Markets,” on November 14 in Tokyo.

Changes in the healthcare system in the U.S. and Europe have a significant impact on the process of introducing new pharmaceutical agents, particularly high-cost specialty drugs such as oncolytics, to these markets. The importance of evaluating benefit assessments from the viewpoint of various stakeholders, such as patients, physicians and insurers, is rapidly rising. This seminar ? led by Gordon Gochenauer, Director, Commercial Planning (U.S.), and Andrew Miniuks, Senior Director, Commercial Planning (Europe) ? will cover:

  • U.S. and European Healthcare Systems: Do patients have access to the needed treatments and medications?
  • Pricing and Reimbursement: Will the drugs be reimbursed by insurance?
  • Stakeholder Relationships: How should pharmaceutical companies build relationships with stakeholders?
  • Case Studies in Oncology: Recent pricing, reimbursement and coverage decisions that highlight similarities and differences between the U.S. and Europe

The seminar will begin at 1 pm. Visit Synix’s website to register for this event (http://www.synix.co.jp/assessment/seminar/20131114/detail.html) or contact Gen Okamoto at market.assessment(at)synix(dot)co(dot)jp for more information.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11270269.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Kantar Health to Highlight Role of Patient-Reported Outcomes in Russia
2. New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
3. Biologic Treatment of Rheumatoid Arthritis Is Low in Brazil, According to Kantar Health Research
4. Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research
5. Kantar Health Americas CEO Mike Kelly Named to PharmaVOICE 100 for 2013
6. Kantar Health Launches CancerMPact Biomarker Analysis
7. Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
8. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
9. Kantar Health to Present at PBIRG Annual General Meeting
10. AACR honors Hagop Kantarjian for outstanding clinical research
11. Kantar Health to Participate in CIO Summit of America Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
Breaking Medicine Technology: